donors may be the most appropriate application due to time-insensitive typing needs and availability of suitable high-throughput technologies.
Blood group genotyping is gaining widespread adoption in blood centres and transfusion services (Denomme et al, 2011; Denomme, 2013; Flegel et al, 2015) . A variety of methods have been described for the molecular analysis of KEL, SLC14A1, DARC, GYPA, and GYPB and the detection of their allelic variants encoding clinically relevant blood group antigens, such as those belonging to the K, Jk, Fy, and MNSs systems (Hashmi et al, 2005; Montpetit et al, 2006; Polin et al, 2008; Hopp et al, 2010; Jungbauer et al, 2012; HaerWigman et al, 2013; McBean et al, 2014; Meyer et al, 2014) . Many of these techniques promise high-throughput processing. However, there is no universally accepted definition of this notion.
Matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry (MALDI-TOF MS) based blood group genotyping delivered impressive concordance rates between blood group genotypes and phenotypes, ranging between 99Á96% and 99Á31% for the antithetic blood group antigens K/k, Jk a/b , Fy a/b , M/N, and S/s (Table I) . Regularly, typing errors were more prevalent in serotyping than in genotyping and there are far fewer data published for M/N and S/s than for K, Jk and Fy (Table I) . The blood group antigens M/N and S/s are encoded on GYPA and GYPB, respectively (Daniels, 2002; Reid et al, 2012) . Single nucleotide substitutions, genetic hybrids and gene duplication events (potentially involving a third, highly homologous GYPE gene) underlie variant MNSs antigens, ranking the MNSs blood group system second in complexity to the Rh blood group system (Reid, 2009 ). Glycophorin C and glycophorin D -an abridged version of glycophorin C -are both predetermined by GYPC (Le Van Kim et al, 1987; el-Maliki et al, 1989) . GYPC encodes for antigens of the Ge (Gerbich) blood group system, but does not share any sequence homology with GYPA, GYPB, or GYPE (Le Van Kim et al, 1987) . Analysis of nucleotide sequence in non-human primates has actually confirmed that the MNSs genes are classical representatives of paralogous genes or 'paralogs', and has identified GYPA as the ancestral gene from which GYPB and GYPE, but not GYPC, arose by sequential gene duplication (Vignal et al, 1990; Rearden et al, 1993) .
Due to excessive nucleotide sequence homology of the paralogs GYPA, GYPB and GYPE, the molecular prediction of antigens in the MNSs system is technically challenging (Kudo & Fukuda, 1989; Huang et al, 1991) . Thus, primers designed to target single nucleotide polymorphisms (SNPs) of GYPA may simultaneously amplify sequences of GYPB and GYPE and thereby deliver misleading amplicons. The panoply of known and unknown hybrid genes of GYPA, GYPB and GYPE further impedes molecular approaches to dissect MNSs alleles. Table II gives a simplified overview of MNS alleles officially recognized by the International Society of Blood Transfusion (ISBT) and addressed in this manuscript (http://www.isbtweb.org/working-parties/red-cellimmunogenetics-and-blood-group-terminology/).
To address these issues, we used MALDI-TOF MS-based blood group genotyping. This technology has already shown persuasive characteristics in performance, data quality and reproducibility in the genotyping of the K, Jk and Fy blood groups, true high throughput capability and results that were highly concordant with serotyping (Gassner et al, 2013; Meyer et al, 2014 Meyer et al, , 2015 Lopez et al, 2015) .
Materials and methods

Samples
All 5800 samples were sequentially taken from repetitive red blood cell (RBC) donors, and had historic phenotype data for MN and Ss. Donor samples were collected at the seven regional blood transfusion services headed in Basel [total n (tn) = 390, dropout n (dn) = 12, valid n (vn) = 378], Geneva (tn = 24, dn = 1, vn = 23), Lucerne (tn = 226, dn = 0, vn = 226), Lugano (tn = 381, dn = 5, vn = 376), Neuchatel (tn = 141, dn = 1, vn = 140), St. Gallen (tn = 168, dn = 1, vn = 167) and Zurich (tn = 4472, dn = 37, vn = 4435).
According to the ethical committee of the Canton of Zurich, an ethical approval of the study was not mandatory. However, all donors explicitly permitted genetic laboratory investigations by written consent.
A panel of 50 DNA samples of known, or presumptive black African ancestry was included in this study . Due to sample depletion, two of the previously used 48 samples were excluded from the present study. Additionally, two S-s-U-/GYPB*01N homozygous and two U+ W / GYPB*01N/GYPB*03N.04 heterozygous samples, were provided by Marion E. Reid (NY Blood Center, NY, USA) for this study.
Routine serological blood group typing and handling of discrepant results
Standard MN and Ss serology was performed as described before Table I . Selected blood group genotyping approaches. Black and grey background represents discrepant findings between serology and genotyping. Black background indicates samples for which the original phenotype was corrected according to genotyping results (mistyped due to serology). Grey background indicates samples for which the genotyping result needed to be corrected according to the original serology (mistyped due to genotyping). 
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SNPs included in the MALDI-TOF MS MNSs module
The SNPs that were investigated for the common and variant alleles of the GYPA, GYPB and GYPE blood group genes are given in Table III . Assay design, quality control of the primer mixes, and MALDI-TOF MS-based genotyping were done as described before .
Confirmatory blood group genotyping and sequencing
Confirmatory blood group genotyping and serotyping were performed in case of discrepancy on an independent second sample with two exceptions: In these two cases, original serological results and DNAs were used for further analysis. Discrepant results however, were not counted as 'serological' or 'genotyping' errors. MNSs genotyping was performed after manual DNA extraction (Gassner et al, 2013) and using commercially available genotyping kits (RBC-Ready Gene MNSs, Inno-Train GmbH, Kronberg im Taunus, Germany). Sequencing was performed on all samples with confirmed phenotype/genotype discrepancies and for reference purposes on one NNSS phenotype sample with the primers listed in Tables SIA and B. Primer concentration was 300 nmol/l and conditions were those previously described for RHD sequencing (Gassner et al, 2005) . Reference sequences were from one phenotype NNSS individual sequenced in this study (accession number LN880516) and from the NCBI database (accession numbers NG_007470.3, NG_007483.2, and NG_009173.1) (http://www.ncbi.nlm.nih.gov/gv/mhc/xslcgi. cgi?cmd=bgmut/home). ISBT allele names for newly observed alleles were requested from the ISBT terminology committee (http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/).
Bi-specific diagnostic polymerase chain reaction sequencespecific primers (PCR-SSPs) were used to specifically detect GYP*201.01-like/GP.Hil and GYP*401-/St(a) types G and H, and GYP.402/Dantu alleles with the primers listed in Tables SIC and D for linkage analysis (Lo et al, 1991) . Positive amplification control and PCR set-up conditions were as described by Gassner et al (1997) , cycling and agarose gel electrophoresis was performed as described by Crottet et al (2014) .
Allele frequency calculation
Allele-frequencies were estimated by allele counting and were adjusted for serologically hidden and genetically undetected new alleles in heterozygous individuals, according to HardyWeinberg proportions (Tables SI and SII) (Hardy, 1908) .
Materials and methods
Samples
All 5800 samples were sequentially taken from repetitive red blood cell (RBC) donors, and had historic phenotype data for MN and Ss. Donor samples were collected at the seven regional blood transfusion services headed in Basel (total n (tn) = 390, dropout n (dn) = 12, valid n (vn) = 378), Geneva (tn = 24, dn = 1, vn = 23), Lucerne (tn = 226, dn = 0, vn = 226), Lugano (tn = 381, dn = 5, vn = 376), Neuchatel (tn = 141, dn = 1, vn = 140), St. Gallen (tn = 168, dn = 1, vn = 167) and Zurich (tn = 4472, dn = 37, vn = 4435).
A panel of 50 DNA samples of known, or presumptive black African ancestry was included in this study . Due to sample depletion, two of the previously used 48 samples were excluded from the present study. Additionally, two S-s-U-/GYPB*01N homozygous and two U+ W / GYPB*01N/GYPB*03N.04 heterozygous samples, were provided by Marion E. Reid (NY Blood Center) for this study.
Standard MN and Ss serology was performed as described before . 
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Confirmatory blood group genotyping and sequencing
Confirmatory blood group genotyping and serotyping were performed in case of discrepancy on an independent second sample with two exceptions: In these two cases, original serological results and DNAs were used for further analysis. Discrepant results however, were not counted as 'serological' or 'genotyping' errors. MNSs genotyping was performed after manual DNA extraction (Gassner et al, 2013) and using commercially available genotyping kits (RBC-Ready Gene MNSs, Inno-Train GmbH). Sequencing was performed on all samples with confirmed phenotype/genotype discrepancies and for reference purposes on one NNSS phenotype sample with the primers listed in Tables SIA and B. Primer concentration was 300 nmol/l and conditions were those previously described for RHD sequencing (Gassner et al, 2005) . Reference sequences were from one phenotype NNSS individual sequenced in this study (accession number LN880516) and from the NCBI database (accession numbers NG_007470.3, NG_007483.2, and NG_009173.1) (http://www.ncbi.nlm. nih.gov/gv/mhc/xslcgi.cgi?cmd=bgmut/home). ISBT allele names for newly observed alleles were requested from the ISBT terminology committee (http://www.isbtweb.org/ working-parties/red-cell-immunogenetics-and-blood-groupterminology/). Bi-specific diagnostic polymerase chain reaction sequencespecific primers (PCR-SSPs) were used to specifically detect GYP*201.01-like/GP.Hil and GYP*401-/St(a) types G and H, and GYP.402/Dantu alleles with the primers listed in Tables  SIC and D for linkage analysis (Lo et al, 1991) . Positive amplification control and PCR set-up conditions were as described by Gassner et al (1997) , cycling and agarose gel electrophoresis was performed as described by Crottet et al (2014) .
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Allele frequency calculation
Results
The MNSs module: a single multiplex reaction with typing capability for 8 SNPs
The MNSs blood group genotyping module is a single multiplex reaction, comprising a total of 3 biallelic and 2 triallelic SNP assays for the simultaneous genetic analysis of M, N, Vw, Hut, Mt(a), S, s, and He. Additionally, a mutated splice site at the 5th nucleotide of intron 5, specific for GYPB*03N, with a pronouncedly weakened expression of U was detected (Huang et al, 1997; Storry et al, 2003) . Furthermore, two inter-genetic polymorphisms, approximately located at positions 9 kbp and 16 kbp of intron 1 of GYPA, GYPB and GYPE were interrogated to allow for respective gene copy number variation estimates (Table SI) (Huang et al, 1987) .
High-throughput MALDI-TOF MS-based genotyping was performed in eight independent typing runs over 8 d, excluding DNA extraction and analysis of data. Calling failures were caused by samples with negative results for all SNPs (total DNA dropouts n = 41), single SNP assay failures per sample (n = 15), and one sample with suspected DNA cross-contamination (n = 1) and were all excluded from the final 5743 donor data set further analysed, resulting in a total calling failure rate of 0Á98% (57/5800).
Performance comparison between Zurich and Hamburg
A random set of 760 blinded samples was chosen to assess the reproducibility of MALDI-TOF MS-based MNSs blood group genotyping using mass spectrometers in two independent laboratories. All process steps, from oligonucleotide order to data analysis, were autonomously carried out in Zurich and Hamburg. Assay performance revealed raw data call rates of 94Á6% (Zurich) and 94Á3% (Hamburg). Additional manual post-processing cluster analysis led to final call rates of 98Á8% (Zurich) and 98Á6% (Hamburg). Out of a total of 72 non-templated control samples (H 2 O) analysed per centre, provided one and five false positive calls in different individual assays, in Zurich and Hamburg, respectively. Final findings of 3412 replicate genotypes showed 100% genotyping concordance between the two sites.
Common and variant GYPA alleles among Swiss
Congruent results comprised 1711 MM (including 1 GYPA*09/Vw positive), 2807 MN (10 GYPA*14/Mt(a) and 4 GYPA*09/Vw positives), and 1208 NN (4 GYPA*14/Mt(a) and 4 GYPA*09/Vw positives), resulting in a phenotypegenotype concordance rate of 99Á70% (5726/5743). Phenotypes Vw, Mt(a) and Mg were confirmed serologically on three GYPA*09, nine GYPA*14 and one GYPA*11 positive genotypes, respectively. Four MM, ten MN and three NN phenotypes were discrepant to the respective genotype (17/ 5743), with four MM (1 without follow up), three MN (1 without follow up), and three NN that could be explained by serological mistypings. Phenotypes were then corrected according to the corresponding genotype (Fig 1) .
Genotyping results of all remaining seven individuals with MM genotypes and MN phenotypes were confirmed to be negative for GYPA*02(T59) by commercially available PCR-SSP typing kits and sequencing of GYPA exon 2, in all cases. In addition, amplification with primers forward-specific for GYPB intron 2 and reverse-specific for GYPA intron 3 or intron 4 indicated the presence of GYPB-A hybrid-genes for all samples. Sequencing allowed the detection of one GYPB-A-B, with high similarity to GYP*201.01/GP.Hil and two types of GYPB-A hybrid alleles, both with high similarity to GYP*401/St(a) and two and four representatives each. For two samples, the break-point was positioned close to exon 3 and in four samples approximately 500 bp after the exon 3/ intron 3 border, respectively. For both newly detected GYP*401/St(a) cases, antigen positivity for St(a) was confirmed serologically on one sample each. The new GYP*401 alleles show similarity with previously reported alleles found in St(a) positive samples dubbed St(a) type A-F. Until now, St(a), encoded by GYPB-A molecules have been described in detail for St(a) type A in two independent Black Americans (Huang & Blumenfeld, 1991a) , type B in two independent Japanese (Huang & Blumenfeld, 1991a) , type C in an 'Oriental' family (Huang & Blumenfeld, 1991b) , type D in one Polish family (Suchanowska et al, 2010) and type E and F in Taiwanese (Chen et al, 2014) (Fig 2) . Our two new GYP*401 alleles were genetically different from those described previously, and therefore may be defined as St(a) type G and H. Sequences were deposited under accession numbers LN880514 for GYP*401 type G, and LN880515 for GYP*401 type H (Fig 2) .
The GYP*201.01-like/GP.Hil-like allele showed a complete insertion of the expressed GYPA exon 3 at the homologous sequence of GYPB (accession number LN880513, Fig 2) . In contrast, the originally described GYP*201.01 was reported to be located on GYPA (Fig 3) (Huang & Blumenfeld, 1991b) .
However, predicting both their primary structures, these two forms only differ by one single amino acid exchange, namely a glutamic acid at position 13 specific for GYP*201.01, to alanine at the same position in our GYP*201.01-like allele. Serologically, antigenic expression of our GYP*201.01-like allele was indistinguishable from the originally reported pheno-and genotyping on GYPA and GYPB, respectively. The vast majority of samples showed full concordance between phenotype and genotype (no background). Black background indicates samples for which the original phenotype was corrected according to genotyping results ('serological mistypes'). Grey background indicates samples for which the genotyping result needed to be corrected according to the original serology ('genetic mistypes'). Simultaneously, all samples with grey background were sequenced unveiling variant alleles in all cases. GYPB*06, GYP*201 and GYP*401 are explicitly listed in the left panel to indicate their actual genetic background differing from GYPA. § without follow up.
Fig 2.
An alignment of informative nucleotide polymorphisms for GYPA (blue), GYPB (red) and GYPE (grey) reference sequences and previously known and new GYP*401/St(a) and GYP*201.01-like alleles. Reference sequences are shown in the 4 top lines. Exon 3 of GYPA and pseudo-exons 3 (w) of GYPB and GYPE (boxed) adjacent intronic sequences, and exon 4 of GYPA and GYPB and pseudo-exon 4 (w) of GYPE (boxed) are given. Breakpoint regions between GYPB and GYPA are indicated by white letters on black background. Deleted nucleotides are given as '-', nucleotides not given are represented by a dot. Centred horizontally, previously published GYP*401/St(a) types A to F and GYP*401/St(a) types G and H identified in this study are given. For the new GYP*401/St(a) alleles, breakpoint region between GYPB and GYPA could be located between T of i3 + 25 and G of i3 + 246 (type E), and A of i3 + 500 and T of i3 + 574 (type F). All GYP*401 breakpoint regions are unique. The two sequences displayed at the bottom are the previously published GYP*201.01/GP.Hil and the new GYP*201.01 -like/GP.Hil-like sequence, observed during this study (Huang et al, 1992) . Allele GYP*201.01-like showed a complete insertion of the expressed GYPA exon 3 between GYPB specific C of i2-360 and T of i3 + 490. Whereas the two alleles exhibit a completely different molecular background (Fig 3) , predicted primary structures only differ by a glutamic acid at position 13 found in GYP*201.01, versus alanine at the same position in GYP*201.01-like. Ignoring the reference sequence of GYPE, exact breakpoint regions could be narrowed down further. Frequencies for all common and variant GYPA and GYPB alleles were calculated and adjusted for serologically hidden and genetically undetected GYP*201.01-like and GYP*401 alleles (Table SII) .
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Common and variant GYPB alleles among Swiss
Genotyping was fully congruent with phenotyping in 619 SS, 2416 Ss and 2702 ss samples, resulting in a concordance-rate of 99Á90% (5737/5743). Three discrepancies were due to serological mistypings with subsequent corrections of two Ss to one SS and one ss phenotype (Fig 1) . Sequencing of the third serological mistyping with a reported ss phenotype delivered a GYPB*24 allele (deposited under accession number LN880518) and was serologically positive for a weakly expressed S and 'Mitchell', in accordance with previous reports on GYPB*24 (Storry et al, 2001 ).
Of the remaining three discrepancies, one sample showed a GYPB*04 genotype, but had an Ss phenotype. Sequencing revealed a variant GYPB*03 with a new G145A(Gly49Arg) mutation (accession number LN880519), exactly located in an elongation-primer binding-site of the MALDI-TOF MS MNSs module.
Two other samples showed the same new GYPB*03 null-allele with a G218A(Gly73Asp) substitution in two Snegative phenotypes (accession number LN880517). One Swiss donor had an apparent MNSs phenotype and showed simultaneous genetic positivity for GYPA*01(C59), negativity for GYPA*02(T59) and positivity for G59, all together indicating the presence of an allele termed GYPB*06, known to express the N-like antigen Henshaw (He) but actually located on GYPB (Huang et al, 1994) . Linkage of G59 to T147(MNS*03) could be proven and narrowed the allele designation to GYPB*06.02. Frequencies of all GYPB alleles were calculated and adjusted for serologically hidden and genetically undetected GYPB*03 (N.G218A), GYPB*03(G145A) and GYPB*24 given in Fig 3. Schematic presentation of genes for GYPA, GYPB and GYPE in different GYP haplotypes. A schematic presentation of genes for GYPA, GYPB and GYPE are given in blue, red and grey, respectively. Boxes represent exons. 'w' represents pseudo-exons of GYPB and GYPE with sequence homology to the respective parts of GYPA. Correct splicing of dashed w -exons into mature mRNA of the respective genes is avoided. GP.wt represents a wild-type GYP locus. GP.S-s-U-stands for a hypothetical variation from a previous description with an almost complete deletion of GYPB, causative of a S-s-U-phenotype in homozygous status (Rahuel et al, 1991) . GP.Dantu, encoded by the allele GYP.402, is one representative of a haplotype with a duplicated GYPB-A hybrid gene, resulting in four GYP genes per GYP-locus. Appearance and composition of GYPB may vary in GP.Dantu haplotypes and is therefore given in a dashed box. GP.Sch, is one representative with positivity for the low frequency antigen St(a), encoded by the allele GYP*401. Several GYP*401 alleles are known and are commonly found on GYP haplotypes including GYPB-A hybrid gene duplications. In this study two new GYP*401 alleles, termed type G and H were described, adding to the genetic complexity of previously known GYP*401 alleles type A to F (Daniels, 2013) . GP.HF is encoded by a GYPB-A-B hybrid allele, positive for the Mur antigen. GP.Hil is a GYPA-B hybrid gene, encoded by GYP*201.01. GP.Hil-like, another new observation of this study, is a GYPB-A-B hybrid gene, thus with a completely different molecular background to GYP*201.01 (Huang et al, 1992; Daniels, 2013) . 'B' and 'E' indicate position 16 kbp of intron 1 used for GYPB:GYPE gene copy number ratio detection. Ideally, expected GYPB:GYPE ratio values are given below each GYP haplotype listed. In physical samples and depending on its type, the second parental GYP haplotype will affect respective ratio values accordingly. Based on an illustration in Daniels (2013) .
GYP gene copy number measurement
The area under the curve of peak signals was measured for GYPA versus GYPB and GYPB versus GYPE, by the detection of gene-specific nucleotides approximately located at positions 9 kbp and 16 kbp in intron 1 of the highly homologous genetic regions, respectively. Whereas the assay at position 9 kbp did not deliver any informative results (data not shown) data retrieved from position 16 kbp allowed for GYPB versus GYPE gene copy number estimates (Fig 4A) . The two types of outliers were observed in 0Á35% of the samples (20/5743), suggesting a reduced GYPB gene content (ratio < 0Á65), and in 0Á71% of the samples (41/5743), suggesting an increased GYPB gene content (ratio > 1Á35), respectively. In the 20 individuals with an apparently reduced GYPB gene content, observation of only seven Ss heterozygous versus 13 (presumably) ss homozygous individuals deviated strongly from an expected Hardy-Weinberg disequilibrium (7/13 = 0,5385 vs. 2415/2702 = 0,8938, counts taken from Fig 1) , suggesting (partial) deletion(s) of GYPB (*03) in these cases.
In the arbitrarily defined group of 41 individuals with a supposedly increased GYPB gene content, four out of six GYP*401/St(a) allele carriers were detected, who had been originally identified due to GYPA*01 homozygosity, but with a discrepant MN heterozygous phenotype. The suggested presence of a fourth, duplicated GYPB-A allele in these cases, is in line with previous reports on GYP*401/St(a) positive haplotypes (Fig 2) (Huang & Blumenfeld, 1991a,b; Suchanowska et al, 2010; Chen et al, 2014) .
Among other available samples with the highest GYPB: GYPE ratios, bi-specific diagnostic PCR-SSPs were used to directly detect additional GYP*401/St(a) allele-carriers, with one individual found among 21 NN pheno/genotypes, and other five among 25 MN pheno/genotypes. In total, 12 GYP*401 allele carriers were identified among 5743 Swiss donors. Nine of them accounted for roughly 22% of all 41 (A) (B) (C) Fig 4. GYPB:GYPE intron 1, position 16kbp, ratio values. The raw area under the curve of peak signals intensities for GYPE were in total 39% higher for all 5743 data points obtained and therefore adjusted to match the theoretically expected GYPB:GYPE gene copy number ratio of 1:1, as expected for the majority of samples. Ratio is indicated on the y-axis, number of samples are given on the x-axis. (A) Ratio values for all 5743 Swiss donor samples tested are shown. Ratio values range from 0Á28 to 1Á92, indicating uneven GYPB:GYPE gene copy numbers in a minority of samples. (B) Samples with GYPB:GYPE ratio values lower than 0Á65 (n = 20/5743, 0Á35%), and higher than 1Á35 are shown (n = 41/5743, 0Á71%). In between, three additional samples with ratio values of 1Á06 (filled circle), 1Á28 (filled triangle) and 1Á33 (open triangle) are given. Circles represent samples positive for the allele GYP*401/St(a) type G and triangles represent samples positive for the allele GYP*401/St(a) type H. Filled symbols represent the first index samples where discrepancy between phenotype MN and genotype MM became apparent (Fig 1, left panel) . Open symbols represent additional heterozygous GYP*401 allele G (circle) and H (triangle) carriers without evident discrepancies between phenoand genotype. All of them were identified by diagnostic PCR-SSPs among other samples with elevated GYPB:GYPE ratios:
The most left open triangle was found in an individual with NN phenotype, all other open symbols represent individuals with a MN phenotype. (C) Ratio values for 50 DNA samples of individuals with presumptive Black African ancestry are shown. Previously known U negative and U+ W phenotypes with double and haploid GYPB deletion are indicated by black circles, respectively. Open circles are samples with GYPB:GYPE gene ratios in between 0Á38 and 0Á47, indicative for the deletion GYPB, e.g. GYPB*01N positivity, on one of the two paternal chromosomes. individuals with elevated GYPB ratios (>1Á35, Fig 4B) . No attempts were made to test individuals for the presence of additional GYP*401 allele-carriers among samples with normal GYPB:GYPE ratios (between 0Á65 and 1Á35).
Given that elevated GYPB gene ratios result from a similar molecular event, as does GYP*401/St(a), all samples with elevated GYPB gene ratio values were investigated for an assumed presence of GYP.402/Dantu (Fig 3) (Huang & Blumenfeld, 1988; Huang et al, 1995) . No GYP.402/Dantu positives were observed. However, these results must be taken cautiously, since no GYP.402/Dantu positive samples were available for use as positive controls. Neither potentially reduced GYPE, nor actually reduced GYPB gene copy numbers were further investigated.
GYP genotyping of 50 individuals with known or presumptive black African origin For a panel of 50 DNA samples with known or presumptive black African ancestry, GYPB versus GYPE gene copy number variation was estimated as described above. Two previously defined S-s-U-phenotype samples showed a complete absence of GYPB at position 16 kbp in intron 1 (ratio 0Á00). Unexpectedly, one of these had a heterozygous 143C/T SNP located in GYPB exon 3, usually indicative of an Ss phenotype. This observation could suggest the presence of at least three different haplotypes in these two samples, with either complete or partial GYPB deletions, each recessively causative of S-s-U-phenotypes.
Furthermore, two previously defined U+ W positive samples were positive for GYPB*03N.04, as indicated by the simultaneous presence of G59 and i5 + 5t. The two samples had a GYPB:GYPE ratio of 0Á31 and 0Á61, indicating the deletion of GYPB on the other paternal haplotype. Two further samples without previous data also showed GYPB*03N.04 on one paternal haplotype, were both heterozygous for 143C/T and had divergent GYPB:GYPE ratios of 0Á48 and 0Á88, respectively. In these two cases, the lower ratio would suggest a heterozygous GYPB*01N/GYPB*03N.04, the higher a GYPB*04/GYPB*03N.04 genotype, with an expectedly expressed s. However, this assumption could not be proven because no Ss serological determination was available for these samples. Of the 44 remaining samples, five delivered reduced GYPB:GYPE ratios between 0Á38 and 0Á47, indicating the presence of only one GYPB gene as detected in intron 1 and a second GYP haplotype with a deleted GYPB gene termed GYPB*01N. All remaining 39 samples showed regular GYPB: GYPE ratios ranging between 0Á68 and 1Á16 (Fig 4C) .
Linkage analysis
Linkage of GYPA*09 Vw and GYPA*14/Mt(a) positive samples with coding nucleotide 59 on GYPA, specific for M or N was directly tested by bi-specific PCR-SSPs. Eight out of nine GYPA*09 positive samples were in linkage with T59, and one with C59, indicating an 89% (8/9) linkage of Vw with N and only 11% with M (1/9). All GYPA*14 positive samples showed linkage of coding nucleotide T59 on GYPA with T230 of the same allele, indicating an exclusive linkage of Mt (a) with N (data not shown). All these observations were in line with previously published data (Daniels, 2002) .
On GYPB, all G59 positive samples, including the four black African cases and the single example from the 5743 Swiss cohort, were located on a GYPB*03 allele (nucleotide T147, exon 3), as tested by bi-specific PCR-SSPs (data not shown). Therefore, expression of He-specific G59 would most likely be expected together with S (nucleotide T147) in most cases. However, the four cases found among black Africans were simultaneously found positive for the i5 + 5t mutation, indicating the presence of GYPB*03N.04, with postulated S positivity at a U+ W phenotype expression level (Storry et al, 2003) . Our GYP*201.01-like mutant was linked to GYPA*01(M) and had an expressed s, as shown by the sequencing results and deduced from the Ss heterozygous phenotype. The observed haplotype linkages for GYP*401 alleles were as follows: three of five GYP*401 type G alleles were unequivocally located on a GYPA*01(M)-GYPB*04(s) haplotype, whereas two were observed in Ss heterozygous samples and therefore unpredictable; four of seven GYP*401 type H were found on a GYPA*01(M)-GYPB*04(s) haplotype, one on GYPA*01(M)-GYPB*03(S), one on GYP*02(N), and the last on GYPA*01 (M), the latter two have unpredictable further linkage, as both were heterozygous for Ss.
Discussion
General performance of MALDI-TOF MS-based genotyping for MN and Ss detection
The concordance rate of phenotypes and genotypes for MN genotyping on GYPA and Ss genotyping on GYPB were 99Á70% and 99Á90%, respectively. Cleared for serological typing errors, our results show a genotyping accuracy of 99Á88% (5736/5743) and 99Á95% (5740/5743) for MN and Ss, respectively. Looking at the 46344 SNP genotype data sets of this study (8 SNPs per 5743 plus 50 samples), and after exclusion of the calling failures, there was not a single genotyping error due to methodological insufficiency. All observed 'genotyping errors' could be explained by rarely occurring genetic variants of common alleles or by new alleles. Similar to the previously reported module for MALDI-TOF MS-based genotyping of K, Jk, and Fy, throughput capacity and robustness of findings for MNSs genotyping are highly competitive as compared to serotyping and other published highthroughput genotyping methods (Hashmi et al, 2005; Montpetit et al, 2006; Polin et al, 2008; Hopp et al, 2010; Jungbauer et al, 2012; Haer-Wigman et al, 2013; McBean et al, 2014; Meyer et al, 2014) . Consequently, from a technological point of view, blood donor serotyping for MNSs blood groups can be complemented or, theoretically, even replaced by genotyping. Improved S-s-U-genotyping employing GYPB gene copy number estimates MALDI-TOF MS has already shown to provide reliable gene number estimates for RHD relative to RHCE (Gassner et al, 2013) . In our study, this methodological property of MALDI-TOF MS was applied at the MNSs-locus on chromosome 4q31.21, detecting GYPB:GYPE gene copy number ratios for each individual donor. Beside the duplication of GYP genes, as known from the GYP*401 allele family, deletion of GYPB in S-s-U-individuals proved to be indicative of the phenotypic variability of antigens of the MNSs blood group system (Fig 4) (Reid, 2009 ).
In our study, known S-s-U-individuals completely lacked GYPB-specific sequences with coinciding GYPB:GYPE ratios of 0Á0, and samples with known heterozygosity for S-s-Uencoding haplotypes showed reduced GYPB contents. As expected, such findings were much more prevalent among Black Africans as compared to the mainly Caucasian Swiss cohort, e.g. 10Á87% (5/46) vs. 0Á35% (20/5743). Due to migration, some individuals with a deletion of GYPB were to be expected among the Swiss donor population, and could offer a plausible explanation for the 20 Swiss individuals with an apparently reduced GYPB:GYPE ratio [Federal Department of Justice and Police (FDJP), State Secretariat for Migration (SEM) of the Swiss Confederation, 2015].
However, the molecular cause for S-s-U-, e.g., the precise breakpoint(s) of the GYPB deletion(s), is currently unknown and therefore direct positive molecular detection is not possible, though highly desirable. Consequently, all GYPB deleted heterozygous and compound heterozygous genotypes remain non-comprehensive in this context and harbour uncertainty in deducing phenotypes from genotyping. Assuming that there are more than one causative haplotype for S-s-U-, e.g., caused by different (partial) deletions of GYPB, accurate genotyping of compound heterozygotes would be even more uncertain. In our study, we addressed this issue by estimating GYPB:GYPE gene copy number and show the relevance of such information in addition to SNP-based typing of MN and Ss. GYP*401 type G and H positive haplotypes encode St(a) and N, but genotype negative for GYP*02
With respect to MN genotyping on GYPA, three types of variant alleles became apparent and are of considerable impact: all showed unambiguous expression of N, while being genetically GYPA*02(N) negative.
A new GYPB-A-B hybrid gene was detected, which appears phenotypically as Hil but has a different molecular background compared to the first reported Hil genotype with a GYPA-B hybrid gene, dubbed GYP*201.01 (Huang & Blumenfeld, 1991b) . Additionally, our GYP*201.01-like allele shows remarkable similarity to GYP.504, one expressing Mur (Fig 3) , which is one of the most important RBC phenotypes in Southeast Asia. This allele needs to be considered in Mur genotyping strategies, because carriers of GYP*201.01-like would wrongly be detected as Mur positive (Hsu et al, 2013) .
A far more frequent observation concerned the two newly identified GYPB-A hybrid alleles, most frequently found in individuals with elevated GYPB gene contents. The observations are in line with previous reports on GYP haplotypes encoding the low incidence antigen St(a). St(a) is encoded by GYPA-B-A, GYPA-E-A, and GYPB-A-B-A hybrid genes in a few individuals, but it is usually associated with a duplicated GYPB-A molecule located between GYPA and GYPB, explaining duplicated GYPB gene counts when assessed in intron 1 (Figs 3, 4) (Daniels, 2013) . St(a) is far more frequent in East Asian populations than in Caucasians [6% in Japan (Madden et al, 1964) vs. 0Á1% in Europeans (Cleghorn, 1962; Metaxas & Metaxas-Buhler, 1972 )], and comprises types A-F encoded by GYPB-A (Huang & Blumenfeld, 1991a,b; Suchanowska et al, 2010; Chen et al, 2014) . The St(a) alleles differ in their exact breakpoint positions in intron 3 of the respective GYPB-A hybrid genes. We found two new St(a) genotypes, both with new GYPB-A intron 3 breakpoints, which point to an antigen frequency of 0Á21 (12/5743) in the investigated Swiss-Caucasian population. We propose to term the new GYP*401 alleles 'type G' and 'type H'.
The relevance of these newly discovered alleles lies not only in their expression of the low incidence antigen St(a) of approximately 0Á35% (1/286), but in the simultaneous expression of commonly detectable N despite negativity for the prototypic GYP*02(N) SNP. GYP*01(M) homozygous individuals may therefore be misinterpreted as M+N-phenotypes if St(a) GYPB-A hybrid alleles are present, and this may be expected at a frequency of approximately 0Á35% (1/ 286) among GYP*01(M) homozygotes in Switzerland. In contrast to unexpressed, so called 'null-'alleles, which show simultaneous antigen negativity and genetic positivity, these St(a) alleles are an example of the opposite, e.g., presenting antigen positivity with 'genetic negativity'. Therefore, such alleles bear a risk in donor genotyping if exclusively genetic approaches are applied, and thus should be considered in SNP-based GYPA and GYPB genotyping.
Conclusions
The measurement of the GYP gene content by MALDI-TOF MS with estimation of gene ratio, provides a reliable and helpful tool for genotyping the MNS blood group antigens, a system with a complex molecular background and of high clinical relevance, also allowing the detection of variants in a heterozygous state (Daniels, 2002) . Measurement of GYP gene content, and further extending this potential to two,
MALDI-TOF MS blood group MNSs genotyping
ª 2016 John Wiley & Sons Ltd, British Journal of Haematology three, or even more different genetic locations, would offer an elegant and helpful supplement to the currently existing molecular approaches. Facing the growing ethnic complexity of populations, overcoming the drawbacks of serological typing of MNS blood group antigens would lead to a significant optimization of transfusion strategies, and be most relevant in the clinical management of individual cases.
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